Uniunea Europeană - română - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. în plus față de alte medicamente pentru tratamentul diabetului zaharat de tip 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Uniunea Europeană - română - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. în plus față de alte medicamente pentru tratamentul diabetului zaharat de tip 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

astrazeneca ab - dapagliflozinum - comprimate filmate - 10 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan hungary kft. - ungaria - dapagliflozinum - compr. film. - 10mg - antidiabetice orale si parenterale, exclusiv insuline

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan hungary kft. - ungaria - dapagliflozinum - compr. film. - 5mg - antidiabetice orale si parenterale, exclusiv insuline

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka, d.d. novo mesto - slovenia - dapagliflozinum - compr. film. - 10mg - antidiabetice orale si parenterale, exclusiv insuline

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka, d.d. novo mesto - slovenia - dapagliflozinum - compr. film. - 5mg - antidiabetice orale si parenterale, exclusiv insuline

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan hungary kft. - ungaria - dapagliflozinum - compr. film. - 10mg - antidiabetice orale si parenterale, exclusiv insuline

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan hungary kft. - ungaria - dapagliflozinum - compr. film. - 5mg - antidiabetice orale si parenterale, exclusiv insuline